Lanreotide Subcutaneous and Oxybutynin Transdermal System
Determining the interaction of Lanreotide Subcutaneous and Oxybutynin Transdermal System and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Oxycodone
- Lanreotide Subcutaneous-Oxycodone and acetaminophen
- Lanreotide Subcutaneous-Oxycodone and Acetaminophen Capsules
- Lanreotide Subcutaneous-Oxycodone and Acetaminophen Capsules and Tablets
- Lanreotide Subcutaneous-Oxycodone and Acetaminophen Extended-Release Tablets
- Lanreotide Subcutaneous-Oxycodone and Acetaminophen Oral Solution
- Oxybutynin Transdermal System-Lansoprazole
- Oxybutynin Transdermal System-Lansoprazole Delayed-Release Capsules
- Oxybutynin Transdermal System-Lansoprazole Orally Disintegrating Tablets
- Oxybutynin Transdermal System-Lansoprazole, Amoxicillin, and Clarithromycin
- Oxybutynin Transdermal System-Lanthanum
- Oxybutynin Transdermal System-Lanthanum carbonate